The importance of SEMA3A in autoimmune disorders is highlighted by the finding of reduced expression of SEMA3A in patients with rheumatoid arthritis and SLE that correlates with T-cell mediated inflammation and disease severity [21]. The gene discussed is SEMA3A; the disease is systemic lupus erythematosus.